US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist
  • 1.5300
  • -0.1600-9.47%
Close Nov 1 16:00 ET
  • 1.5600
  • +0.0300+1.96%
Post 20:02 ET
313.56MMarket Cap-3122P/E (TTM)

Taysha Gene Therapies Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-53.57%1.11M
-27.52%3.41M
517.55%15.45M
44.04%3.6M
4.75M
2.4M
4.71M
2.5M
2.5M
0
Operating revenue
-53.57%1.11M
-27.52%3.41M
517.55%15.45M
44.04%3.6M
--4.75M
--2.4M
--4.71M
--2.5M
--2.5M
--0
Cost of revenue
Gross profit
Operating expense
-13.06%22.41M
30.45%27.74M
-32.45%86.83M
-3.23%19.4M
-19.94%20.38M
-22.75%25.78M
-57.17%21.27M
-25.82%128.53M
-59.68%20.05M
-49.77%25.46M
Selling and administrative expenses
22.55%7.34M
-19.05%7.08M
-19.57%30.05M
-8.47%6.72M
-1.08%8.59M
-39.31%5.99M
-23.70%8.75M
-9.59%37.36M
-37.82%7.34M
-22.15%8.68M
-General and administrative expense
22.55%7.34M
-19.05%7.08M
-19.57%30.05M
-8.47%6.72M
-1.08%8.59M
-39.31%5.99M
-23.70%8.75M
-9.59%37.36M
-37.82%7.34M
-22.15%8.68M
Research and development costs
-23.84%15.07M
65.07%20.66M
-37.72%56.78M
-0.20%12.68M
-29.71%11.79M
-15.80%19.79M
-67.23%12.51M
-30.90%91.17M
-66.49%12.71M
-57.56%16.77M
Operating profit
8.92%-21.3M
-46.93%-24.33M
43.37%-71.37M
9.97%-15.8M
38.59%-15.63M
29.93%-23.38M
66.65%-16.56M
27.26%-126.03M
64.71%-17.55M
49.77%-25.46M
Net non-operating interest income expense
216.11%1.41M
257.73%1.66M
59.82%-1.43M
209.22%1.21M
66.14%-362K
-69.97%-1.22M
-60.33%-1.06M
-182.56%-3.55M
-67.07%-1.11M
-111.26%-1.07M
Non-operating interest income
545.74%1.44M
430.72%1.69M
1,334.54%3.57M
865.33%1.92M
12,222.22%1.11M
725.93%223K
2,178.57%319K
44.77%249K
586.21%199K
-75.68%9K
Non-operating interest expense
-98.13%27K
-97.89%29K
31.60%5M
-45.36%713K
36.46%1.47M
93.81%1.44M
104.46%1.37M
165.97%3.8M
88.86%1.31M
98.53%1.08M
Other net income (expense)
-34,833.33%-1.04M
-17,337.50%-1.4M
-6.39%-38.77M
271.11%62.33M
-10,109,000.00%-101.09M
200.00%3K
0.00%-8K
-36.44M
-36.43M
-1K
Gain on sale of security
--195K
---337K
---34.72M
--65.74M
---100.46M
----
----
----
----
----
Special income (charges)
----
----
93.24%-2.46M
94.93%-1.85M
---616K
----
----
---36.42M
---36.42M
--0
-Less:Impairment of capital assets
----
----
-97.08%1.07M
-98.77%449K
--616K
----
----
--36.42M
--36.42M
--0
-Less:Other special charges
----
----
--1.4M
----
----
----
----
----
----
----
Other non- operating income (expenses)
-41,333.33%-1.24M
-13,125.00%-1.06M
-8,705.56%-1.59M
-25,916.67%-1.56M
-1,800.00%-19K
200.00%3K
0.00%-8K
---18K
---6K
---1K
Income before tax
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
-341.39%-117.09M
27.85%-24.6M
64.98%-17.62M
4.88%-166.01M
-9.31%-55.08M
48.18%-26.53M
Income tax
Net income
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
-341.39%-117.09M
27.85%-24.6M
64.98%-17.62M
4.88%-166.01M
-9.31%-55.08M
48.18%-26.53M
Net income continuous Operations
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
-341.39%-117.09M
27.85%-24.6M
64.98%-17.62M
4.88%-166.01M
-9.31%-55.08M
48.18%-26.53M
Minority interest income
Net income attributable to the parent company
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
-341.39%-117.09M
27.85%-24.6M
64.98%-17.62M
4.88%-166.01M
-9.31%-55.08M
48.18%-26.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
-341.39%-117.09M
27.85%-24.6M
64.98%-17.62M
4.88%-166.01M
-9.31%-55.08M
48.18%-26.53M
Basic earnings per share
76.32%-0.09
64.29%-0.1
74.60%-0.96
125.79%0.2554
-43.08%-0.93
55.29%-0.38
78.79%-0.28
18.53%-3.78
25.00%-0.99
51.85%-0.65
Diluted earnings per share
76.32%-0.09
64.29%-0.1
74.60%-0.96
125.79%0.2554
-43.08%-0.93
55.29%-0.38
78.79%-0.28
18.53%-3.78
25.00%-0.99
51.85%-0.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -53.57%1.11M-27.52%3.41M517.55%15.45M44.04%3.6M4.75M2.4M4.71M2.5M2.5M0
Operating revenue -53.57%1.11M-27.52%3.41M517.55%15.45M44.04%3.6M--4.75M--2.4M--4.71M--2.5M--2.5M--0
Cost of revenue
Gross profit
Operating expense -13.06%22.41M30.45%27.74M-32.45%86.83M-3.23%19.4M-19.94%20.38M-22.75%25.78M-57.17%21.27M-25.82%128.53M-59.68%20.05M-49.77%25.46M
Selling and administrative expenses 22.55%7.34M-19.05%7.08M-19.57%30.05M-8.47%6.72M-1.08%8.59M-39.31%5.99M-23.70%8.75M-9.59%37.36M-37.82%7.34M-22.15%8.68M
-General and administrative expense 22.55%7.34M-19.05%7.08M-19.57%30.05M-8.47%6.72M-1.08%8.59M-39.31%5.99M-23.70%8.75M-9.59%37.36M-37.82%7.34M-22.15%8.68M
Research and development costs -23.84%15.07M65.07%20.66M-37.72%56.78M-0.20%12.68M-29.71%11.79M-15.80%19.79M-67.23%12.51M-30.90%91.17M-66.49%12.71M-57.56%16.77M
Operating profit 8.92%-21.3M-46.93%-24.33M43.37%-71.37M9.97%-15.8M38.59%-15.63M29.93%-23.38M66.65%-16.56M27.26%-126.03M64.71%-17.55M49.77%-25.46M
Net non-operating interest income expense 216.11%1.41M257.73%1.66M59.82%-1.43M209.22%1.21M66.14%-362K-69.97%-1.22M-60.33%-1.06M-182.56%-3.55M-67.07%-1.11M-111.26%-1.07M
Non-operating interest income 545.74%1.44M430.72%1.69M1,334.54%3.57M865.33%1.92M12,222.22%1.11M725.93%223K2,178.57%319K44.77%249K586.21%199K-75.68%9K
Non-operating interest expense -98.13%27K-97.89%29K31.60%5M-45.36%713K36.46%1.47M93.81%1.44M104.46%1.37M165.97%3.8M88.86%1.31M98.53%1.08M
Other net income (expense) -34,833.33%-1.04M-17,337.50%-1.4M-6.39%-38.77M271.11%62.33M-10,109,000.00%-101.09M200.00%3K0.00%-8K-36.44M-36.43M-1K
Gain on sale of security --195K---337K---34.72M--65.74M---100.46M--------------------
Special income (charges) --------93.24%-2.46M94.93%-1.85M---616K-----------36.42M---36.42M--0
-Less:Impairment of capital assets ---------97.08%1.07M-98.77%449K--616K----------36.42M--36.42M--0
-Less:Other special charges ----------1.4M----------------------------
Other non- operating income (expenses) -41,333.33%-1.24M-13,125.00%-1.06M-8,705.56%-1.59M-25,916.67%-1.56M-1,800.00%-19K200.00%3K0.00%-8K---18K---6K---1K
Income before tax 14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M-341.39%-117.09M27.85%-24.6M64.98%-17.62M4.88%-166.01M-9.31%-55.08M48.18%-26.53M
Income tax
Net income 14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M-341.39%-117.09M27.85%-24.6M64.98%-17.62M4.88%-166.01M-9.31%-55.08M48.18%-26.53M
Net income continuous Operations 14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M-341.39%-117.09M27.85%-24.6M64.98%-17.62M4.88%-166.01M-9.31%-55.08M48.18%-26.53M
Minority interest income
Net income attributable to the parent company 14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M-341.39%-117.09M27.85%-24.6M64.98%-17.62M4.88%-166.01M-9.31%-55.08M48.18%-26.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M-341.39%-117.09M27.85%-24.6M64.98%-17.62M4.88%-166.01M-9.31%-55.08M48.18%-26.53M
Basic earnings per share 76.32%-0.0964.29%-0.174.60%-0.96125.79%0.2554-43.08%-0.9355.29%-0.3878.79%-0.2818.53%-3.7825.00%-0.9951.85%-0.65
Diluted earnings per share 76.32%-0.0964.29%-0.174.60%-0.96125.79%0.2554-43.08%-0.9355.29%-0.3878.79%-0.2818.53%-3.7825.00%-0.9951.85%-0.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data